480 related articles for article (PubMed ID: 17576940)
1. Erythema nodosum-like eruption as a manifestation of azathioprine hypersensitivity in patients with inflammatory bowel disease.
de Fonclare AL; Khosrotehrani K; Aractingi S; Duriez P; Cosnes J; Beaugerie L
Arch Dermatol; 2007 Jun; 143(6):744-8. PubMed ID: 17576940
[TBL] [Abstract][Full Text] [Related]
2. Tolerability and safety of mercaptopurine in azathioprine-intolerant patients with inflammatory bowel disease.
Lees CW; Maan AK; Hansoti B; Satsangi J; Arnott ID
Aliment Pharmacol Ther; 2008 Feb; 27(3):220-7. PubMed ID: 17988235
[TBL] [Abstract][Full Text] [Related]
3. Thioguanine: a potential alternate thiopurine for IBD patients allergic to 6-mercaptopurine or azathioprine.
Dubinsky MC; Feldman EJ; Abreu MT; Targan SR; Vasiliauskas EA
Am J Gastroenterol; 2003 May; 98(5):1058-63. PubMed ID: 12809828
[TBL] [Abstract][Full Text] [Related]
4. Azathioprine hypersensitivity presenting as neutrophilic dermatosis and erythema nodosum.
Cheraghi N; Yasuda M; Deng A; Mailhot J
Cutis; 2016 Jul; 98(1):E7-9. PubMed ID: 27529720
[No Abstract] [Full Text] [Related]
5. Azathioprine in inflammatory bowel disease, a safe alternative?
Tanis AA
Mediators Inflamm; 1998; 7(3):141-4. PubMed ID: 9705598
[TBL] [Abstract][Full Text] [Related]
6. Adverse events leading to modification of therapy in a large cohort of patients with inflammatory bowel disease.
Hindorf U; Lindqvist M; Hildebrand H; Fagerberg U; Almer S
Aliment Pharmacol Ther; 2006 Jul; 24(2):331-42. PubMed ID: 16842460
[TBL] [Abstract][Full Text] [Related]
7. Sweet syndrome as a manifestation of azathioprine hypersensitivity.
El-Azhary RA; Brunner KL; Gibson LE
Mayo Clin Proc; 2008 Sep; 83(9):1026-30. PubMed ID: 18775203
[TBL] [Abstract][Full Text] [Related]
8. Thiopurine methyltransferase (TPMT) activity and adverse effects of azathioprine in inflammatory bowel disease: long-term follow-up study of 394 patients.
Gisbert JP; Niño P; Rodrigo L; Cara C; Guijarro LG
Am J Gastroenterol; 2006 Dec; 101(12):2769-76. PubMed ID: 17026564
[TBL] [Abstract][Full Text] [Related]
9. Thiopurine drug adverse effects in a population of New Zealand patients with inflammatory bowel disease.
Gearry RB; Barclay ML; Burt MJ; Collett JA; Chapman BA
Pharmacoepidemiol Drug Saf; 2004 Aug; 13(8):563-7. PubMed ID: 15317038
[TBL] [Abstract][Full Text] [Related]
10. Adverse effects of azathioprine in the treatment of inflammatory bowel disease.
Martínez F; Nos P; Pastor M; Garrigues V; Ponce J
Rev Esp Enferm Dig; 2001 Dec; 93(12):769-78. PubMed ID: 11995359
[TBL] [Abstract][Full Text] [Related]
11. Arthralgia and Fevers in a Patient With Autoimmune Hepatitis.
Ardalan ZS; Vasudevan A; Testro AG
JAMA; 2016 Jul; 316(1):91-2. PubMed ID: 27380346
[No Abstract] [Full Text] [Related]
12. Azathioprine-Induced Hypersensitivity Reaction Presenting as Erythema Nodosum.
González-Olivares M; Khedaoui R; Martínez-Morán C; Borbujo J
Actas Dermosifiliogr; 2017; 108(6):591-593. PubMed ID: 28262113
[No Abstract] [Full Text] [Related]
13. Azathioprine hypersensitivity: report of two cases and review of the literature.
Sinico RA; Sabadini E; Borlandelli S; Cosci P; Di Toma L; Imbasciati E
J Nephrol; 2003; 16(2):272-6. PubMed ID: 12768076
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous manifestations in inflammatory bowel diseases: eight cases of psoriasis induced by anti-tumor-necrosis-factor antibody therapy.
Passarini B; Infusino SD; Barbieri E; Varotti E; Gionchetti P; Rizzello F; Morselli C; Tambasco R; Campieri M
Dermatology; 2007; 215(4):295-300. PubMed ID: 17911986
[TBL] [Abstract][Full Text] [Related]
15. Diffuse febrile dermatosis in a patient with active ulcerative colitis under treatment with steroids and azathioprine: a case of Sweet's syndrome. Case report and review of literature.
Paoluzi OA; Crispino P; Amantea A; Pica R; Iacopini F; Consolazio A; Di Palma V; Rivera M; Paoluzi P
Dig Liver Dis; 2004 May; 36(5):361-6. PubMed ID: 15191207
[TBL] [Abstract][Full Text] [Related]
16. Thiopurine-S-methyltransferase genotype and the response to azathioprine in inflammatory bowel disease.
Stocco G; Martelossi S; Decorti G; Bartoli F; Ventura A
Aliment Pharmacol Ther; 2007 Oct; 26(7):1083-4; author reply 1084-5. PubMed ID: 17877516
[No Abstract] [Full Text] [Related]
17. [Erythema nodosum and Crohn's disease].
Areias E; García E Silva L
Med Cutan Ibero Lat Am; 1984; 12(6):489-95. PubMed ID: 6152299
[TBL] [Abstract][Full Text] [Related]
18. Increased rates of early adverse reaction to azathioprine in patients with Crohn's disease compared to autoimmune hepatitis: a tertiary referral center experience.
Bajaj JS; Saeian K; Varma RR; Franco J; Knox JF; Podoll J; Emmons J; Levy M; Binion DG
Am J Gastroenterol; 2005 May; 100(5):1121-5. PubMed ID: 15842588
[TBL] [Abstract][Full Text] [Related]
19. Desensitization of patients with allergic reactions to immunosuppressives in the treatment of inflammatory bowel disease.
Korelitz BI; Reddy B; Bratcher J
Expert Opin Drug Saf; 2010 May; 9(3):379-82. PubMed ID: 20367524
[TBL] [Abstract][Full Text] [Related]
20. Absence of azathioprine hypersensitivity after administration of its active metabolite 6-mercaptopurine.
Schmitt K; Pfeiffer U; Stiehrle HE; Thuermann PA
Acta Derm Venereol; 2000; 80(2):147-8. PubMed ID: 10877141
[No Abstract] [Full Text] [Related]
[Next] [New Search]
